Anthony Rodgers
0000-0003-1282-1896
Publication & Citation Trends
Publications
0 total
Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial OA
Cited by 54
Semantic Scholar
Calculation of Phase 2 dose‐finding study sample size for reliable Phase 3 dose selection
Cited by 3
Semantic Scholar
Efficacy and Safety of Repeated Subcutaneous Ketamine Injections for Treatment Resistant Depression - The KADS Study: A Randomised, Double-Blind, Comparator-Controlled Trial OA
Cited by 1
Semantic Scholar
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial. OA
Cited by 108
Semantic Scholar
Once-Daily Doravirine in HIV-1-Infected, Antiretroviral-Naive Adults: An Integrated Efficacy Analysis.
Cited by 9
Semantic Scholar
Efficacy, safety and CNS effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine in a randomized controlled trial.
Cited by 4
Semantic Scholar
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial.
Cited by 68
Semantic Scholar
Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive Adults With HIV-1 and Transmitted Nonnucleoside Reverse Transcriptase Inhibitor Resistance Mutations OA
Cited by 19
Semantic Scholar
Research Topics
Blood Pressure and Hypertension Studies
(196)
Health Systems, Economic Evaluations, Quality of Life
(67)
Medication Adherence and Compliance
(64)
Pharmaceutical Economics and Policy
(52)
Hormonal Regulation and Hypertension
(40)
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States)
University of Sydney
University of Tasmania
Dalhousie University
MetroHealth